The global Liquid for Assisted Reproductive Technology market size is predicted to grow from US$ 12260 million in 2025 to US$ 28410 million in 2031; it is expected to grow at a CAGR of 15.0% from 2025 to 2031.

Liquids for human in vitro assisted reproductive technology (hereinafter referred to as ART liquids) refer to liquid medical device products that come into direct or indirect contact with human gametes and/or embryos to prepare, cultivate, transfer or store human gametes and/or embryos, Such as egg collection liquid, egg and embryo treatment liquid, sperm washing liquid, sperm density gradient separation liquid, in vitro fertilization liquid, cleavage embryo culture liquid, gamete/embryo freezing liquid, gamete/embryo thawing liquid, culture oil, etc.

In the "three-child era", as the number of late marriage and late childbearing continues to expand in my country, the average childbearing age increases and the infertility rate rises significantly, people’s demand for assisted reproduction also increases, which promotes the continuous expansion of my country’s assisted reproductive industry.

ReportPrime, Inc. (LPI) ' newest research report, the “Liquid for Assisted Reproductive Technology Industry Forecast” looks at past sales and reviews total world Liquid for Assisted Reproductive Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Liquid for Assisted Reproductive Technology sales for 2025 through 2031.

This Insight Report provides a comprehensive analysis of the global Liquid for Assisted Reproductive Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyzes the strategies of leading global companies with a focus on Liquid for Assisted Reproductive Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid for Assisted Reproductive Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid for Assisted Reproductive Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

Key Features:

• Market shares and growth opportunities of Liquid for Assisted Reproductive Technology market by product type
• Segmentation by application
• Key manufacturers and key regions and countries

Segmentation by Type:

• Egg Wash
• Semen
• Coolant
• Thawing Fluid
• Other

Segmentation by Application:

• Hospital
• Clinic
• Other

Market by region:

• Americas
• APAC
• Europe
• Middle East & Africa

Companies Coverage:

• Vitrolife
• Wallace
• CooperSurgical, Inc.
• William A Cook Australia Pty. Ltd
• FUJIFILM Irvine Scientific, Inc.
• Dewin Medical Technology
• Shenzhen Weituo Biotechnology
• Rubai Bio
• Arsci
• WEGO

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Liquid for Assisted Reproductive Technology market?
• What factors are driving Liquid for Assisted Reproductive Technology market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Liquid for Assisted Reproductive Technology market opportunities vary by end market size?
• How does Liquid for Assisted Reproductive Technology break out by Type, by Application?